Quality of life: The ultimate outcome measure of interventions in major depressive disorder

Harvard Review of Psychiatry

Volumn 19, Issue 5, 2011, Pages 229-239

  Ishak, Waguih William ^a,b   Greenberg, Jared Matt ^a   Balayan, Konstantin ^b   Kapitanski, Nina ^c   Jeffrey, Jessica ^a   Fathy, Hassan ^d   Fakhry, Hala ^e   Rapaport, Mark Hyman ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

Major depression; Mood disorders; Quality of life

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; HERBACEOUS AGENT; LITHIUM; MONOAMINE OXIDASE INHIBITOR; OMEGA 3 FATTY ACID; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

COGNITIVE THERAPY; COMORBIDITY; DISEASE SEVERITY; EUROPEAN QUALITY OF LIFE; EXERCISE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; HUMOR; MAJOR DEPRESSION; MASSAGE; MEDITATION; MEDLINE; MENTAL HEALTH CARE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCINFO; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; QUALITY OF LIFE IN DEPRESSION SCALE; QUALITY OF WELL BEING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REMISSION; REVIEW; SELF REPORT; SHORT FORM 12; SHORT FORM 36; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; VALIDITY; WELLBEING; WORK AND SOCIAL ADJUSTMENT SCALE; WORLD HEALTH ORGANIZATION QUALITY OF LIFE ASSESSMENT INSTRUMENT;

DEPRESSIVE DISORDER, MAJOR; HUMANS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 80052915387     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.3109/10673229.2011.614099     Document Type: Review

References (79)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504. (Pubitemid 27216360)
2. World Health Organization. Mental health and substance abuse. Facts and figures. Conquering depression. 2006. At http://www.searo.who.int/en/ Section1174/Section1199/Section1567/Section1826.htm
3. Commonwealth Department of Health and Aged Care; Australian Institute of Health and Welfare. National health priority areas report: mental health 1998. Canberra, Australia, 1999. http://aihw.gov.au/publication-detail/?id = 6442467062
4. Kessler RC, Chiu WT, DemlerO,Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005;62:617-27. (Pubitemid 40973437)
5. Zung WW, Broadhead WE, Roth ME. Prevalence of depressive symptoms in primary care. J Fam Pract 1993;37:337-44. (Pubitemid 23303211)
6. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008;300:2379-88.
7. Carney RM, Blumenthal JA, Freedland KE, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005;165:1486-91. (Pubitemid 41058028)
8. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretrovi-ral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005;38:432-8. (Pubitemid 40381553)
9. Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother 2009;63:636-40.
10. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008;70:539-45.
11. Regan KL. Depression treatment with selective serotonin reup-take inhibitors for the postacute coronary syndrome population: a literature review. J Cardiovasc Nurs 2008;23:489-96.
12. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 2008;47:384-90. (Pubitemid 351619427)
13. Walkup J, Wei W, Sambamoorthi U, Crystal S. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q 2008;79:43-53.
14. World Health Organization. Preamble to the Constitution of the World Health Organization. 1948. http://www.who.int/governance/eb/who constitution en.pdf
15. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend 2007;88(suppl 2):S61-71. (Pubitemid 46528065)
16. Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs 2010;24:267-84.
17. World Health Organization Quality of Life Group. Measuring quality of life. 1997. http://www.who.int/mental health/media/68.pdf
18. IsHak WW, Burt T, Sederer LI, eds. Outcome measurement in psychiatry: a critical review. Washington, DC: American Psychiatric Publishing, 2002.
19. IsHak WW. Outcome assessment in depression. Psychiatr Times 2008;25:10-2.
20. Gershon RC, Rothrock N, Hanrahan R, Bass M, Cella D. The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. J Appl Meas 2010;11:304-14.
21. Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol 2010;63:1195-204.
22. Owens DK. In the eye of the beholder: assessment of health-related quality of life. Hepatology 1998;27:292-3.
23. da Rocha NS, Power MJ, Bushnell DM, Fleck MP. Is there a measurement overlap between depressive symptoms and quality of life? Compr Psychiatry 2009;50:549-55.
24. Trompenaars FJ, Masthoff ED, Van Heck GL, Hodiamont PP, De Vries J. Relationship between mood related disorders and quality of life in a population of Dutch adult psychiatric outpatients. Depress Anxiety 2006;23:353-63. (Pubitemid 44619787)
25. Moore M, Hofer S, McGee H, Ring L. Can the concept of depression and quality of life be integrated using a time perspective? Health Qual Life Outcomes 2005;3:1-10.
26. Berlim M, Fleck M. Quality of life and major depression. In: Ritsner MS, Awad AG, eds. Quality of life impairment in schizophrenia, mood, and anxiety disorders. Dordrecht, Netherlands: Springer, 2007.
27. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression: treatment manual. New York: Guilford, 1979.
28. Aigner M, Forster-Streffleur S, Prause W, Freidl M, Weiss M, Bach M. What does the WHOQOL-BREF measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc Psychiatry Psy-chiatr Epidemiol 2006;41:81-6.
29. Ritsner M. The distress/protection vulnerability model of quality of life impairment syndrome. In: Ritsner MS, Awad AG, eds. Quality of life impairment in schizophrenia, mood, and anxiety disorders. Dordrecht, Netherlands: Springer, 2007.
30. Ritsner M, Modai I, Endicott J, et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000;61:880-9.
31. Church MC. The conceptual and operational definition of quality of life: a systematic review of the literature [master of science thesis (Texas A&M University, 2004)]. http://repository.tamu.edu/bitstream/handle/1969.1/2771/etd- tamu-2004B-HEED-Church.pdf?sequence = 1
32. World Health Organization Quality of Life Group. The World Health Organization quality of life (WHOQOL) assessment: position paper from the World Health Organization. Soc Sci Med 1995;10:1403-9.
33. World Health Organization. WHOQOL-BREF. 2004. http://www.who.int/ substance abuse/research tools/en/english who qol.pdf.
34. World Health Organization. The World Health Organization Quality of Life (WHOQOL)-BREF: introduction, administration, scoring and generic version of the assessment. http://www.who.int/mental health/media/en/76.pdf
35. Corring DJ, Cook JV. Use of qualitative methods to explore the quality-of-life construct from a consumer perspective. Psychiatr Serv 2007;58:240-4. (Pubitemid 46340469)
36. Kaplan RM, Ganiats TG, Sieber WJ, Anderson JP. The Quality of Well-Being scale: critical similarities and differences with SF-36. Int J Qual Health Care 1998;10:509-20. (Pubitemid 29037244)
37. Mathews WC, May S. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care. Health Qual Life Outcomes 2007;5:5.
38. Savoia E, Fantini MP, Pandolfi PP. Assessing the construct validity of the Italian version of the EQ-5D: preliminary results from a cross-sectional study in North Italy. Health Qual Life Outcomes 2006;4:47.
39. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-83.
40. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS SF-36 Short-Form Health Survey (SF-36), III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
41. Rush AJ, First MB, Blacker D, eds. Handbook of psychiatric measures. 2nd ed. Washington, DC: American Psychiatric Publishing, 2008.
42. McKenna SP, Hunt SM. A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy 1992;22:321-30.
43. DeJonghe F, McKenna SP. Quality of Life in Depression Scale (QLDS): development, reliability, validity, responsiveness and application. Eur Psychiatry 1997;12:199-202. (Pubitemid 27246654)
44. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-6. (Pubitemid 23311543)
45. Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005;162:1171-8. (Pubitemid 40770701)
46. Skevington S, Wright A. Changes in the quality of life of the patients receiving antidepressant medication in primary care: validation of the WHOQOL-100. Br J Psychiatry 2001;178:261-7. (Pubitemid 32183610)
47. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHO-QOL group. Qual Life Res 2004;13:299-310. (Pubitemid 38392258)
48. Daly EJ, Trivedi MH, Wisniewski SR, et al. Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry 2010;22:43-55.
49. Ezquiaga E, Garćia-López A, de Dios C, Leiva A, Bravo M, Montejo J. Clinical and psychosocial factors associated with the outcome of unipolar major depression: a one year prospective study. J Affect Disord 2004;79:63-70. (Pubitemid 38340530)
50. Bonicatto SC, Dew MA, Zaratiegui R, Lorenzo L, Pecina P. Adult outpatients with depression: worse quality of life than in other chronic medical diseases in Argentina. Soc Sci Med 2001;52:911-9. (Pubitemid 32013900)
51. Saarijärvi S, Salminen JK, Toikka T, Raitasalo R. Health-related quality of life among patients with major depression. Nord J Psychiatry 2002;56:261-4.
52. Mittal D, Fortney J, Pyne J, Edlund M, Wetherell J. Impact of comorbid anxiety disorders on health-related quality of life among patients with major depressive disorder. Psychiatr Serv 2006;57:1731-7. (Pubitemid 46051327)
53. Brieger P, Ehrt U, Bloeink R, Marneros A. Consequences of co-morbid personality disorders in major depression. J Nerv Ment Dis 2002;190:304-9. (Pubitemid 34533661)
54. Abrams RC, Alexopoulos GS, Spielman LA, Klausner E, Kakuma T. Personality disorder symptoms predict declines in global functioning and quality of life in elderly depressed patients. Am J Geriatr Psychiatry 2001;9:67-71. (Pubitemid 32062074)
55. Saatcioglu O, Yapici A, Cakmak D. Quality of life, depression and anxiety in alcohol dependence. Drug Alcohol Rev 2008;27:83-90.
56. Holzapel N, Zugck C, Muller-Tasch T, Lowe B. Routine screening for depression and quality of life in outpatients with congestive heart failure. Psychosomatics 2007;48:112-6. (Pubitemid 46362571)
57. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003;29:215-21. (Pubitemid 37430060)
58. Swenson JR, O'Connor CM, Barton D, Van Zyl L. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003;92:1271-6. (Pubitemid 37431133)
59. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004;27:1066-70. (Pubitemid 38579767)
60. Cully J, Graham MS, Stanley M, Ferguson C. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2004;47: 312-9.
61. Adewuya AO, Afolabi MO, Ola BA, et al. Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med 2008;38:43-51.
62. Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 1996;153:1411-7. (Pubitemid 26365454)
63. Pyne JM, Patterson TL, Kaplan RM, Gillin JC, Koch WL, Grant I. Assessment of the quality of life of patients with major depression. Psychiatr Serv 1997;48:224-30. (Pubitemid 27057407)
64. Fleck MP, Simon G, HerrmanH, BushnellD, Martin M,Patrick D. Major depression and its correlates in primary care settings in six countries. Br J Psychiatry 2005;186:41-7. (Pubitemid 40070542)
65. Berlim MT, Mattevi BS, Fleck MP. Depression and quality of life among depressed Brazilian outpatients. Psychiatr Serv 2003;54:254. (Pubitemid 36752863)
66. Berlim MT, McGirr A, Fleck MP. Can sociodemographic and clinical variables predict the quality of life of outpatients with major depression? Psychiatry Res 2008;160:364-71.
67. Trivedi HM, Rush AJ, Wisniewski RS, et al. Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry 2006;67:185-95. (Pubitemid 43357463)
68. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nieren-berg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 2004;26:13-7. (Pubitemid 38142561)
69. Shelton RC, Haman KL, Rapaport MH, et al. A randomized, double-blind, active-control study of sertraline versus ven-lafaxine XR in major depressive disorder. J Clin Psychiatry 2006;67:1674-81. (Pubitemid 44955146)
70. Reed C, Monz BU, Perahia DG, et al. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER. J Affect Disord 2009;113:296-302.
71. Angermeyer MC, Holzinger A, Matschinger H, Stenger-Wenzke K. Depression and quality of life: results of a follow-up study. Int J Soc Psychiatry 2002;48:189-99.
72. Acil AA, Dogan S, Dogan O. The effects of physical exercises to mental state and quality of life in patients with schizophrenia. J Psychiatr Ment Health Nurs 2008;15:808-15.
73. Larun L, Nordheim LV, Ekeland E, Hagen KB, Heian F. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database Syst Rev 2006;3:CD004691.
74. Nykĺicek I, Kuijpers KF. Effects of mindfulness-based stress reduction intervention on psychological well-being and quality of life: is increased mindfulness indeed the mechanism? Ann Behav Med 2008;35:331-40.
75. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H. Rhythmical massage therapy in chronic disease: a 4-year prospective cohort study. J Altern Complement Med 2007;13:635-42. (Pubitemid 47357085)
76. Marziali E, McDonald L, Donahue P. The role of coping humor in the physical and mental health of older adults. Aging Ment Health 2008;12:713-8.
77. Wong DF. Cognitive and health-related outcomes of group cognitive behavioural treatment for people with depressive symptoms in Hong Kong: randomized wait-list control study. Aust N Z J Psychiatry 2008;42:702-11.
78. Van der Watt G, Laugharne J, Janca A. Complementary and alternative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry 2008;21:37-42. (Pubitemid 351339806)
79. IsHak WW, Davis M, Jeffrey J, et al. The role of dopaminergic agents in improving quality of life in major depressive disorder. Curr Psychiatry Rep 2009;11:503-8.